References
- Hassold T, Jacobs P. Trisomy in man. Annu Rev Genet 1984;18:69–97.
- Antonarakis SE. Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group. N Engl J Med 1991;324:872–6.
- Yoon PW, Freeman SB, Sherman SL, et al. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population based study. Am J Hum Genet 1996;58:628–33.
- Bullock AN, Fersht AR. Rescuing the function of mutant p53. Nat Rev Cancer 2001;168–76.
- Thompson SL, Compton DA. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 2010;188:369–81.
- Dumont P, Leu JI, Della Pietra AC, III, et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003;33:357–65.
- Thomas M, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092–100.
- Hu W. The role of p53 gene family in reproduction. Cold Spring Harb Perspect Biol 2009;1:a001073. doi: 10.1101/cshperspect.a001073.
- Boquett JA, Brandalize AP, Fraga LR, et al. Maternal SNPs in the p53 pathway: risk factors for trisomy 21? Dis Mark 2013;34:41–9.
- Michele S, Salluzzo MG, Calogero AE, et al. Association study of COX-2 (PTGS2) -765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer’s disease. Arch Med Sci 2014;22:1235–8.